RXi Pharmaceuticals Corporation announced that its Board of Directors has appointed Dr. Jonathan Freeman as an independent director of the company, effectively immediately. In addition, he will be a member of the Company's Audit and Nominating committees. Dr. Jonathan Freeman serves as the Chief Business Officer at Vedanta Biosciences with an initial emphasis in autoimmune and inflammatory diseases. Previously, Dr. Freeman was Senior Vice President, Head of Strategy Development and Portfolio Management at Merck KGaA.